Cyclerion Therapeutics (CYCN) Receivables (2020 - 2025)
Historic Receivables for Cyclerion Therapeutics (CYCN) over the last 6 years, with Q3 2025 value amounting to $100000.0.
- Cyclerion Therapeutics' Receivables rose 12727.27% to $100000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $100000.0, marking a year-over-year increase of 12727.27%. This contributed to the annual value of $556000.0 for FY2024, which is N/A changed from last year.
- Latest data reveals that Cyclerion Therapeutics reported Receivables of $100000.0 as of Q3 2025, which was up 12727.27% from $525000.0 recorded in Q2 2025.
- Over the past 5 years, Cyclerion Therapeutics' Receivables peaked at $581000.0 during Q1 2025, and registered a low of $44000.0 during Q3 2024.
- Its 5-year average for Receivables is $244750.0, with a median of $192500.0 in 2021.
- Its Receivables has fluctuated over the past 5 years, first plummeted by 5770.93% in 2023, then skyrocketed by 12727.27% in 2025.
- Quarter analysis of 5 years shows Cyclerion Therapeutics' Receivables stood at $100000.0 in 2021, then dropped by 4.0% to $96000.0 in 2022, then changed by 0.0% to $96000.0 in 2023, then skyrocketed by 479.17% to $556000.0 in 2024, then tumbled by 82.01% to $100000.0 in 2025.
- Its Receivables was $100000.0 in Q3 2025, compared to $525000.0 in Q2 2025 and $581000.0 in Q1 2025.